Sanofi announces a first-class cooperation with Formation Bio and OpenAI, to build artificial intelligence-powered software to accelerate drug development and deliver new drugs more efficiently.

In this collaboration, the first of its kind in healthcare, the three teams will bring together tailored data, software and models to develop customized solutions tailored to the entire drug development cycle.

Sanofi will leverage this partnership to provide access to proprietary data to develop AI models in its drive to become the first large-scale AI-optimized biopharmaceutical company.

Copyright (c) 2024 All rights reserved.